PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
This is a 3-arm, randomized, double-blind, double-dummy, and controlled clinical study over 6
months of treatment to evaluate the metabolic and clinical efficacy as well as the safety of
DLBS3233 alone, metformin and combination of both, in improving metabolic and reproductive
parameters.